体弱住院老年股骨近端骨折患者非手术与手术管理的成本效用分析:一项多中心前瞻性队列研究
该研究纳入荷兰172例预期寿命有限的体弱住院老年股骨近端骨折患者,88例(51%)选择非手术治疗,84例(49%)选择手术治疗。非手术治疗6个月医疗成本更低(2425欧元 vs 9325欧元,p<0.001),但手术组每获得一个QALY的ICER为76912欧元,超过每QALY 20000欧元的阈值。作者认为对于临终体弱患者,应在共同决策中公开讨论非手术治疗。
要点
- 非手术治疗6个月医疗成本显著低于手术治疗(2425欧元 vs 9325欧元,p<0.001)。
- 手术组每获得一个QALY的ICER为76912欧元,超过每QALY 20000欧元的阈值。
- 在伤后14天和30天内死亡的患者中,手术组获得的QALY极少但成本超过三倍。
核心结论
- 手术治疗导致显著更高的医疗成本,主要归因于住院时间。
- 对于临终体弱患者,股骨近端骨折的非手术治疗应在共同决策对话中公开讨论,因为生活质量获益有限。
研究设计与样本
- 多中心前瞻性队列研究,纳入荷兰172例预期寿命有限、年龄≥70岁的住院体弱股骨近端骨折患者。
- 计算医院和养老院护理成本,基于EuroQol-5D-5L效用评分在第7天、14天、30天及3个月、6个月计算QALY,从社会视角计算ICER。
主要发现
- 172例入组患者中,88例(51%)选择非手术治疗,84例(49%)选择手术治疗。
- 主要成本驱动为住院时间:非手术治疗738欧元(SD 841),手术治疗3140欧元(SD 2636)。
- 手术治疗相对于非手术治疗的每QALY增量成本效用比为76912欧元,超过每QALY 20000欧元的阈值。
- 在伤后14天和30天内死亡的患者中,手术组获得的QALY极少,但手术导致成本超过三倍。
关键数值与推荐
- 住院时间成本:非手术治疗738欧元(SD 841) vs 手术治疗3140欧元(SD 2636)。
- 手术治疗 vs 非手术治疗的ICER为每QALY 76912欧元,超过每QALY 20000欧元的阈值。
临床怎么用
- 对于临终体弱患者,股骨近端骨折的非手术治疗应在共同决策对话中公开讨论,因为生活质量获益有限。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Hip fractures are associated with significant healthcare costs. In frail institutionalized patients, the costs of nonoperative management are less than operative management with comparable short-term quality of life. Nonoperative management of hip fractures in patients at the end of life should be openly discussed with SDM. PURPOSE: The aim was to describe healthcare use with associated costs and to determine cost-utility of nonoperative management (NOM) versus operative management (OM) of frail institutionalized older patients with a proximal femoral fracture. METHODS: This study included institutionalized patients with a limited life expectancy aged ≥ 70 years who sustained a proximal femoral fracture in the Netherlands. Costs of hospital- and nursing home care were calculated. Quality adjusted life years (QALY) were calculated based on EuroQol-5D-5L utility scores at day 7, 14, and 30 and at 3 and 6 months. The incremental cost-effectiveness ratio (ICER) was calculated from a societal perspective. RESULTS: Of the 172 enrolled patients, 88 (51%) patients opted for NOM and 84 (49%) for OM. NOM was associated with lower healthcare costs at 6 months (NOM; €2425 (SD 1.030), OM; €9325 (SD 4242), p < 0.001). The main cost driver was hospital stay (NOM; €738 (SD 841) and OM; €3140 (SD 2636)). The ICER per QALY gained in the OM versus NOM was €76,912 and exceeded the threshold of €20,000 per QALY. The gained QALY were minimal in the OM group in patients who died within 14- and 30-day post-injury, but OM resulted in more than triple the costs. CONCLUSION: OM results in significant higher healthcare costs, mainly due to the length of hospital stay. For frail patients at the end of life, NOM of proximal femoral fractures should be openly discussed in SDM conversations due to the limited gain in QoL. TRIAL REGISTRATION: Netherlands Trial Register (NTR7245; date 10-06-2018).
引用
- Loggers SAI, Geraerds AJLM, Joosse P, et al. Nonoperative versus operative management of frail institutionalized older patients with a proximal femoral fracture: a cost-utility analysis alongside a multicenter prospective cohort study. Osteoporos Int. 2023. PMID: 36609506. doi:10.1007/s00198-022-06638-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。